In re Disposable Contact Lens Antitrust Litigation: Appointed co-lead counsel in a case concerning an alleged price-fixing conspiracy involving four dominant manufacturers of disposable contact lenses in the United States.
In re Air Cargo Shipping Services Antitrust Litigation – Partial Settlement: Over $1 billion in partial settlements for an alleged global conspiracy to fix surcharges for air cargo shipping services.
In re Automotive Parts Antitrust Class Action: Involving alleged price-fixing conspiracies as to various automotive parts that are components of new motor vehicles. Partial settlement to date of almost $200 million.
In re Polyurethane Foam Antitrust Litigation: Over $433 million in settlements regarding an alleged conspiracy to unlawfully fix the prices of polyurethane foam in the United States.
Oxbow Carbon & Minerals LLC, et al. v. Union Pacific Railroad Company, et al.: Recently retained to represent Oxbow, an opt-out plaintiff in the In re Rail Freight Fuel Surcharge Antitrust Litigation, 07-cv-0489, MDL No. 1869, (D.D.C.), class action, in connection with its claims against defendants, Union Pacific Railroad Company and BNSF Railway Company for allegedly conspiring to increase revenue by imposing non-negotiable fuel surcharges on rail shipments. Oxbow further alleges that defendants conspired to grant Union Pacific a monopoly over a track of land in the western part of the United States.
In re Imprelis Herbicide Marketing, Sales Practices and Products Liability Litigation: Involving alleged misrepresentations by DuPont regarding the safety of and environmental damage resulting from use of Imprelis herbicide. (Prior to joining Robins Kaplan LLP)
In re Lorazepam and Clorazepate Antitrust Litigation: $147 million settlement for claims that Mylan Laboratories, Inc. implemented unlawful and anticompetitive price increases for generic versions of the anti-anxiety drugs Lorazepam and Clorazepate. (Prior to joining Robins Kaplan LLP)
In re Abbott Laboratories Norvir Antitrust Litigation: $10 million settlement stemming from Abbott Laboratories’ price increase of Norvir, which provides for a payment to non-profit organizations serving individuals with HIV. (Prior to joining Robins Kaplan LLP)
In re Marine Hose Antitrust Litigation: $32 million settlement on behalf of businesses injured by an alleged conspiracy to fix the prices of marine hose. (Prior to joining Robins Kaplan LLP)
In re Puerto Rican Cabotage Antitrust Litigation: $52 million settlement for an alleged conspiracy to fix the prices of ocean freight services between the continental United States and Puerto Rico. (Prior to joining Robins Kaplan LLP)
In re Brand Name Prescription Drug Indirect Purchaser Antitrust Litigation: Ms. Salzman was principally responsible for administering a $65 million multi-state settlement to community health centers for subsidizing prescriptions to low-income patients on behalf of retail pharmacies for alleged price discrimination by pharmaceutical manufacturers. (Prior to joining Robins Kaplan LLP)